Sanofi releases AVAXIM Junior in the UK
Therapy provides immunisation against infection caused by hepatitis A in children aged 12 months to 15 years
Read More
Tag: Launch
Suliqua launches in UK
The approval is based on two phase III studies, LixiLan-O and LixiLan-L.
Read More
PharmaTimes is proud to announce the launch of the 2019 Sales Awards!
This year’s event builds on the phenomenal success of the 2018 re-launch of this highly respected competition – recognising and rewarding the most talented sales professionals working within the healthcare industry.
Read More
Herceptin biosimilar Herzuma launched in Europe
Mundipharma announced that its network of companies has kicked off the rollout of Celltrion’s Herceptin biosimilar Herzuma in Europe.
Read More
Amicus kicks off launch of Galafold in the UK
Amicus Therapeutics has kicked off the commercial launch of its rare disease therapy Galafold in the UK after it was endorsed for reimbursement within the NHS by the National Institute for Health and Care Excellence’s Highly Specialised Technologies Evaluation Committee.
Read More
UK launch for Cardiome’s skin infections antibiotic
A one- or two-shot antibiotic has been launched in the UK for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
